MR. HUMAYUN DHANRAJGIR has a very rich and varied experience in the pharmaceutical industry. He has held several senior management positions including that of the Vice Chairman & Managing Director of Glaxo India Limited. He is a former President of the Organization of Pharmaceutical Producers of India (O.P.P.I). Mr. Dhanrajgir joined the Board of the Company in September,2000.

Mr. Dhanrajgir is a graduate in Chemical Engineering from Loughborough Universiy, U.K.Member  -  Institution  of  Chemical  Engineers,  U.K.  Chartered  Engineer,  U.K.  and  has completed the Advanced Management Program of Harvard Business School.

Some of the companies in which Mr. Dhanrajgir is an Independent Non-Executive Director are  Cadila  Healthcare  Limited, HDFC  Asset  Management  Company  Limited, Neuland Laboratories Limited, Next Gen Publishing Limited. He is also a Trustee of Breach Candy Hospital Trust, Mumbai and on the Advisory Board of U.S.Pharmacopeia (India).

 

MR. BERJIS DESAI specialises in mergers and acquisitions, derivatives, corporate and financial laws, international business laws and international commercial arbitration. He is the  Managing  Partner  of  J. Sagar  Associates, a  national  law  firm  in  Mumbai, Delhi, Bangalore, Hyderabad and Dubai. Mr. Berjis Desai has a long association with the Company. He joined the Company a Director in April,1997.

Mr. Berjis Desai is a law graduate from the Mumbai University and a post-graduate in law from the Cambridge University.

Some of the companies in which Mr. Berjis Desai is Director are Praj Industries Limited, Adlabs Films Limited, Sterlite Industries (India) Limited, Reliance Asset Reconstruction Company Limited, The Great Eastern Shipping Company Limited and National Organic Chemical Industries Limited.

 

DR. MAHENDRA PATEL has an all round expertise in the areas of Active Pharmaceutical Ingredients, formulation development, Bio-equivalence studies, Intellectual Property and Regulatory Process. He has the honor of holding 30 patents to his credit. He set up and successfully led his own generics company,Invamed,in the USA,which was later acquired by the multinational pharma giant, Sandoz. Dr. Patel has also been associated with large trans- national pharma companies in the USA, like Bristol Myers Squibb and Lederle where he held senior management positions in R&D. Dr. Patel joined the Company as a Director in January, 2005.

Dr.Patel is a Ph.D in Pharmaceutical Science from University of Wisconsin,USA.

Dr.Patel is also on the Board of Zydus Pharmaceuticals USA,Inc.

 

MR. AKHIL  GUPTA  represents  the  Blackstone  Group  on  the  Board  of  the  Company.

Mr. Gupta is Chairman and Managing Director of Blackstone Advisors India Private Limited. Prior to Blackstone, he has worked as CEO – Corporate Development for Reliance Industries Limited  and  Reliance  Infocomm  Limited.  He  has  held  senior  positions  in  various organizations in the USA. He has more than 30 years of experience in the corporate world. Mr.Gupta became the member of the Board of the Company in August,2006.

Mr. Gupta is a B. Tech in Chemical Engineering from IIT, Delhi and MBA from Stanford University,USA.

 

Marvin Samson was formerly Group Vice President – Worldwide Injectables of Teva.  Mr. Samson previously served as President and Chief Executive Officer and a member of the Board of Directors of Sicor.

He is an expert in injectable manufacturing and delivery systems and was a founder, President and Chief Executive Officer of Elkins-Sinn (now a division of Baxter Healthcare) and Marsam Pharmaceuticals. He is the founder and Chief Executive Officer of Samson Medical Technologies, a privately held company providing hospital and alternate site pharmacists with injectable drug delivery systems and programs.

Mr. Samson served as the chairman of the Generic Pharmaceutical Industry Association from 1997 to 2000. Mr. Samson is the holder of five U.S. patents pertaining to pharmaceutical manufacturing.

MR. SATISH MEHTA is the Managing Director and founder member of the Company. He has vast experience in the pharmaceutical industry. He is the prime mover for various strategic alliances and growth plans of the Company. His dynamic leadership has led the Company to become a major player in the pharmaceutical industry.

Mr.Satish Mehta is a Post Graduate in Chemistry and MBA from IIM,Ahmedabad.

MR. ARUNKUMAR KHANNA - Executive Director – heads Operations of the Company. He has over 30 years of rich and varied experience in leading pharma companies like Ranbaxy, Alkem and Cadila.

Since 1995, Mr. Khanna has played a pivotal role in transforming Emcure into the fastest growing Pharma Major. He has also been instrumental in ensuring the wide global reach of Emcure's leading brands. Emcure's Corporate Social Responsibility in the area of HIV/ AIDS has been widely acclaimed and appreciated as a result of his passionate efforts.

MR. MAHESH SHAH is the Director (Technical) and in charge of the entire manufacturing operations of the Company. He has been in the pharmaceutical industry since 1976 and has been associated with Emcure since the Company’s inception.

Besides technical operations, Mr. Shah has also played a lead role in getting regulatory approvals from US FDA,UK MHRA,WHO Geneva and MCC.

Mr.Shah is a Post Graduate in Science.